Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis

Abstract

In recent years, biologists and clinicians have witnessed prominent advances in in vitro 3D culture techniques related to biomimetic human/animal tissue analogs. Numerous data have confirmed that unicellular and multicellular (tumoroids) tumor spheroids with dense native cells in certain matrices are sensitive and valid analytical tools for drug screening, cancer cell dynamic growth, behavior, etc. in laboratory settings. Angiogenesis/vascularization is a very critical biological phenomenon to support oxygen and nutrients to tumor cells within the deep layer of solid masses. It has been shown that endothelial cell (EC)-incorporated or -free spheroid/tumoroid systems provide a relatively reliable biological platform for monitoring the formation of nascent blood vessels in micron/micrometer scales. Besides, the paracrine angiogenic activity of cells within the spheroid/tumoroid systems can be monitored after being treated with different therapeutic approaches. Here, we aimed to collect recent advances and findings related to the monitoring of cancer angiogenesis using unicellular and multicellular tumor spheroids. Vascularized spheroids/tumoroids can help us in the elucidation of mechanisms related to cancer formation, development, and metastasis by monitoring the main influencing factors.

Introduction

Inside the body, cells reside in a specific three-dimensional (3D) microenvironment which is known as a niche. The close interaction between cells and the environment within the defined 3D space can regulate each cell's morphology and function [1]. From the past to the present time, cell culture has been widely used to understand the participation of various molecular pathways, cell behaviors, and the mechanism of diseases and pathological conditions [2]. In this regard, the conventional two-dimensional (2D) culture system is a basic method for the cultivation, expansion, and conduction of several experiments in most laboratories [3]. As a common belief, the 2D culture system is a relatively low-cost and friendly-use in vitro model for large-scale production and harvesting of human and animal cells [2]. In this system, adherent cells are directly attached to a plastic surface predominantly composed of polystyrene-based materials [4]. While the non-adherent cells are expanded without the necessity to attach to the bottom of culturing flasks [5]. Despite these advantages, several issues and limitations restrict the generalization of in vitro data to in vivo conditions. It is postulated that 2D culture systems could not completely reflect the in vivo conditions because of the lack of accurate tissue model structures, cellular heterogeneity, and real-time pathological changes [6]. Generally, the monolayer cell culture systems produce flattened cells with unlimited access to micro-, macro-elements, metabolites, signaling molecules, and growth factors, leading to uncontrolled cell proliferation and expansion, and loss of specified morphologies and functions [7, 8]. Of course, the subcellular localization of organelles, paracrine activity, and stimulation of certain signaling pathways are also changed in cells cultured in 2D systems [9, 10]. Under such conditions, the proteomic, metabolic, and genomic profiles of cells are also changed compared to cells of the same lineages inside the body [11]. Due to the easy distribution of soluble factors in 2D culture systems, even trivial concentrations of therapeutics can evenly affect the cultured cells which is not comparable to the in vivo conditions while in the in vivo microenvironment, there is a competition between the cells to access nutrients and other signaling molecules [12]. ‌Besides, diffusible molecules are delivered to various tissues in a concentration gradient manner [13]. The absence of extracellular matrix (ECM), multiple signals, and mechanical cues inhibit or blunt the activity of certain molecular effectors inside the cells, resulting in low-rate predictability [14]. High-rate proliferation and expansion of cells in 2D culture systems can result in the existence of numerous dead cells with diverse waste products which can affect the physiology of co-expanded cells [15,16,17]. To overcome these limitations, 3D in vitro cell culture systems have been advanced for basic and pre-clinical cancer research [18]. In this regard, Petersen and Bissell presented the 3D organotypic structures to mimic healthy and cancerous breast tissue niches [19]. It is believed that in vitro organoid systems can in part, but not completely, provide the key elements of in vivo conditions via the regulation of cell morphologies, juxtacrine and paracrine activities, and cell-to-ECM interaction [20]. Using various supporting ECM components at different ratios, organoid (tumoroid) microstructure can be developed similar to the native tissues [18]. Despite the existence of different limitations, 3D culture settings provide valuable information about cell behavior for clinical use compared to 2D culture settings [21, 22].

As above-mentioned, the development of optimized biomimetic culture systems with high similarity to in vivo conditions can yield more valid and comparable data [23]. To date, several 3D culture systems have been developed to recapitulate the physiological and pathological conditions (Table 1). Among several 3D culture systems, organoids/spheroids are engineered in vitro micro/macrostructures composed of stem cells, cancer cells, and/or mature cells and have been used for theranostics, large‐scale drug screening, hereditary diseases, and personalized medicine purposes (Table 2) [24, 25]. In this review article, the recent advances in 3D culture systems with a focus on organoids/spheroids will be discussed in terms of stem cell biology and tumor cells.

Table 1 Several techniques have been used for in vitro 3D cell culture and spheroid studies

Table 2 Some unicellular and multicellular spheroids have been used for the evaluation of chemotherapeutics

Different organoid/spheroid systems in biomedical fields

Terms and general features

The advent and development of 3D culture systems have helped biologists in the conduction of numerous animal-free studies for basic biology and clinical research [26]. Irrespective of ethical issues, data from animal studies are relatively inefficient in understanding the physiopathological conditions of human counterparts and could not be completely applied to clinical settings [27]. The cost of drugs and therapeutic applications is high on different animal models. The reproducibility and reliability analyses on animals are under question as different animal strains are treated using rigorous protocols and conditions [28]. Of note, most of the drugs examined in animals fail to yield relatively similar responses in human counterparts because of differences in animal models, strain, dose of therapeutics, and administration route [28]. To be specific, organoids and spheroids are 3D miniaturized tissue structures with either stem cells, mature cells, or even cancer cells to recapitulate the in vivo-like microenvironments and efficient pre-clinical platforms for drug screening and validation [1]. Carcinogenesis and promotion of anaplastic changes coincide with the activation of several sequential processes that provoke cancer cells and non-cancer cells into the tumor stroma [29]. To date, several techniques and approaches have been used for the fabrication of organoids/spheroids, and other 3D culture systems (Table 1 and Fig. 1). Data have confirmed that cells maintained and expanded within the organoid/spheroid/tumoroid system exhibited relatively similar patterns of in vivo dynamic growth and response to therapeutics compared to conventional 2D culture systems [30]. Progress and advancement in 3D culture systems like organoids have led to the compensation of gaps and shortcomings between the 2D culture system and animal models [16, 17]. In this scenario, the 3D culture system exhibits more valuable data about the physiology of cells because of reciprocal cell-to-cell and cell-to-ECM interaction [16, 17].

Fig. 1

Different approaches are used for the development of unicellular (homotypic) and multicellular (heterotypic) tumor spheroids in in vitro conditions. Several studies have been performed to generate tumor spheroids by using different cells such as freshly isolated or cultured primary cells, and cancer and non-cancer cell lines. The cancer cell aggregate is composed of single cancer cells (spheroids) or different cell lineages (multicellular spheroids or tumoroids) using the supporting matrix to maintain the cells within certain sizes. Designed by using BioRender's web-based software

In cancer biology, several tumoroid models have been used for the evaluation of therapeutics as follows; 3D tumor cell culture, 3D tumor slice, patient-derived organoids, vascularized tumoroid, spheroid, and organoid culture models [31,32,33,34,35,36,37]. Most often there is an overlap between the terms spheroids and organoids concerning cellular sources and generation procedure [33]. Spheroids have less complexity and are common 3D structures for preliminary monitoring of anti-cancer drugs while organoids have higher similarities in terms of genetic patterns and histological features to the source tissues and tumors [1]. In the context of cancers, assembling disassociated tumor cells using suitable ECM components generates organoids which are known as tumoroids [31]. It has been proposed that 3D culture systems like organoids are valid tools to simulate tiny tumor masses using several cell types with relatively in vivo-like growth and treatment patterns [16, 17]. To the best of our knowledge, unicellular tumor spheroids have been extensively utilized for cancer cell biology, invasion, and drug screening. However, they do not accurately mimic the intricate biological and clinical characteristics of primary tumor tissues, thus restricting their effectiveness in predicting individualized responses to chemotherapy. In contrast, organoids (known also tumoroids) exhibited more valuable tools for drug screening, disease modeling, and personalized medicine. Tumor organoids can be developed from primary patient samples within a defined 3D framework. It is thought that tumoroids have relatively structural and functional cues like in vivo tumor masses, with a reliable platform for clinical decision-making [38]. Unlike tumoroids, single-cell spheroids lack cell polarity, heterogenicity, and complexity and function of cancer cells within the cancer masses. Thus, organoids reflect more accurately the cellular diversity and physiological roles found in organs [39]. Besides, in stem cell research, organoids composed of tissue-specific stem cells with other specific cell lineages have been used to mimic the architecture and function of the target tissues [40]. Stem cell organoids are effective in vitro modeling tools in the establishment of studies related to developmental processes (organogenesis), regenerative defects, and certain pathophysiological conditions. Retention inside the defined microenvironments helps the stem cells to preserve their stemness while it simultaneously helps us to use naïve or genetically manipulated stem cells for specific regenerative purposes [40].

For conventional organoid/tumoroid development, three main elements including broad-ranging cells (either homogenous or heterogeneous cell type), supporting scaffolds, and endogenous/exogenous signaling molecules can be modulated according to the purpose and objective of the study [1]. In several studies, both natural and synthetic substrates have been used for the generation of organoids/tumoroids to provide a platform for cell attachment, proliferation, and juxtacrine within a 3D structure [41] (Table 1). For generation of organoid/tumoroid structure using natural ECM components, the existence of specific motifs such as Arg-Gly-Asp (RGD) can be useful in providing an in vivo-like microenvironment. Despite the several advantages (toxicity↓, biocompatibility↑, bioactivity↑, and biodegradability↑) related to the application of natural substrates, the final organoids/tumoroids lack appropriate mechanical stability and integrity in response to the changes of certain parameters such as pH and incubation temperature [42]. In line with these comments, the addition of synthetic substrates such as polyurethane (PU)-, polyethylene glycol (PEG)-, poly (lactic-co-glycolic acid) (PLGA)-based composites can yield organoids/tumoroids with higher mechanical properties and resistance to environmental parameters. However, the lack of essential bioactive motifs like RGD, etc. restricts their bulk application in organoid/tumoroid fabrication [43].

Mechanisms related to tumoroid formation

Due to the complexity of the tumor microenvironment (TME) and the involvement of different cell types, it seems that an intricate molecular network is involved in the formation of tumor colonies [44]. Like in vivo conditions, in vitro protocols should be performed with a focus on the stimulation of such molecular interactions and specific cell behavior to promote cell aggregation within distinct dimensions and geometries. In a common belief, the loosely cell-to-cell connection is promoted in in vitro conditions mainly via the attachment of integrins and cadherins to ECM components, leading to the formation of preliminary cell aggregates [45, 46]. The initial spheroid units undergo compaction via the maintenance of homotypic cadherin binding [45]. By the promotion of homotypic (homophilic) cadherin interaction, cells are juxtaposed in contact areas while the surface tension is also diminished [47]. In this regard, E and N-cadherins are the most important cadherin types and they participate in homophilic cell-to-cell attachment [48]. However, the possibility of heterophilic interaction between N and E-cadherins is also possible via physical interactions between the cadherins ectodomains [48]. Upon induction of cadherin-to-cadherin interaction, intracellular actomyosin contractility is stimulated, resulting in cell aggregate morphogenesis [49]. Of course, the type and level of cadherins are associated with the cell lineage. For instance, E-cadherin is actively involved in juxtacrine interaction between the cancer cells rather than cancer stem cells (CSCs). Powan and co-workers indicated that the lack of cell-to-cell connection via cadherin can increase the possibility of apoptosis (p53↑, phosphorylated FAK↓), leading to loss of integrity in tumor cell aggregates [50]. Despite the existence of heterophilic cadherin interaction between the CSC N-cadherin and non-CSC E-cadherin, it seems that this interaction is not highly stable when compared to the homophilic E-cadherin-to-E-cadherin connection. Besides, the conversion of E-cadherin to N-cadherin during the anaplastic changes can reduce the possibility of colony formation and increase the metastatic behavior, leading to the disintegration of multicellular components within the tumoroid systems [51, 52]. Previous data showed the co-precipitation of cytoskeletal proteins like actin with N-cadherin, indicating the ability of N-cadherin to modulate specific cell morphologies between the juxtaposed cells [46]. As above-mentioned, the activity of ECM components along with cell surface adherens can promote the integrity of cell-to-cell junction and thus tumoroid stability. For instance, fibronectin with fibrillar strands can recruit tensin, and α5β1 integrins and strengthen the physical contacts between the cells. The loss of fibronectin can result in N-cadherin ligation recruited α5β1 integrins, tensin, and β-catenin [46]. These data show that cells tend to preserve their juxtacrine interactions using different mechanisms even in the absence of certain ECM components.

Of note, the application of several cells within the tumoroid system can stimulate several cell-to-cell junction pathways. It has been shown that CAFs can secret different fibroblast growth factor members within the ovarian tumor mass [53]. In the presence of FGF-2, the stability of VE-cadherin increases between the juxtaposed ECs via controlling SHP2 [54]. These features can promote blood support into tumor parenchyma and facilitate tumor cell growth and expansion. According to these data, one can hypothesize that the integrity of cells via juxtacrine interaction can be induced via the application of multiple cells within the tumoroid system rather than of unicellular units. Within the tumor parenchyma, ECM is remodeled with the balances between the production and degradation. For example, several cell types such as tumor associate macrophages (TAMs) and CAFs can release various MMPs (MMP2, 7, 9, and 12) along with cytokines such as VEGF and FGF-2 into tumor parenchyma, leading to bulk remodeling of ECM and angiogenesis [55]. Collagen is the most abundant ECM component with the potential to induce cancer fibrosis. The mutual tumor cell-collagen interaction is done via the engagement of several signaling pathways such as transforming growth factor-β (TGF-β)/Smad axis, etc. Collagen fibers in proximity to epithelial cells generate a stiff fibrotic layer via reciprocal interaction between the Smad4 and phosphorylated myosin light chain 2 [56]. Inside tumor parenchyma, several collagen types are produced with diverse biological activities. The orientation, alignment, and stroma stiffness are related to the size and fiber type of collagen in which the long collagen fibers are closely aligned to each other and stabilize cell localization and organization. There is a physical contact between cell surface integrins α (₁, ₂, ₃, ₄, ₁₀, ₁₁)/β₁ subunits with ECM collagen fibers. Unlike long collagen fibers, short fibers can increase the permeability of tumor niches [57]. In terms of angiogenesis, it was suggested that collagen stiffness can influence microvascular integrity and development. Of note, there is an inverse relationship between the microvascular network distribution and collagen fiber density. On the other hand, the increase of inter-collagen fibril branching and spatial arrangement (especially type IV collagen) promotes vascular density and number [57]. In in vitro conditions, the application of collagen with basal membrane components takes approximately five days to generate relatively compact cell aggregates with certain viscoelastic behavior [58]. Therefore, the existence of supporting ECM can support simultaneously reciprocal cell-to-cell and cell-to-ECM interactions.

Tumoroids/spheroids and angiogenesis potential

Tumor angiogenesis

It has been indicated that angiogenesis or neo-vascularization is a critical phenomenon for the development, and expansion of tumor cells within the solid cancer parenchyma [59]. Angiogenesis is the formation of new blood vessels from the pre-existing vascular network while vascularization is the phenomenon of in situ differentiation and expansion of vascular units with the participation of endothelial progenitor cells (EPCs) [60]. Angiogenesis with different signaling pathways, and cell components, especially endothelial cells (ECs) supports blood and oxygen demand to cells exposed to hypoxic conditions [60]. Considering the urgent need for establishing rapid, reproducible, and valid in vitro cancer angiogenesis models for the evaluation of various pro-, and anti-angiogenesis compounds, it seems that the selection of appropriate assays such as tumoroid/spheroid-based assays can help us to understand angiogenesis mechanisms better than conventional cell-based assays [61]. Most commonly used in vitro angiogenesis assays are based on the culture and expansion of ECs on the plastic surface or certain substrates (Table 3) [62]. Notably, 2D culture settings and numerous 3D culture assays can lead to the loss of typical function and phenotype of ECs [63]. Based on previously published data, cultured ECs in 2D culture systems exhibited prominent changes in karyotype, cell-surface antigens, and dynamic growth activity [64]. To achieve suitable angiogenesis potential, ECs must be in a quiescent state to stimulate the juxtaposition of several vascular cells with simultaneous activation of certain pro-angiogenesis factors [65]. Of note, there is no 2D gold-standard and definite angiogenesis assay for the detection of cellular and molecular events [65]. Thus, more angiogenesis-related assays are mandatory to achieve reliable results. It should not be forgotten that most assays use ECs as the only cellular source for angiogenesis assessment while different cell lineages with a high degree of heterogeneity (either structural or functional diversity) participate in blood vessel formation [66]. Noteworthy, the shape and size of ECs, and the complexity of junctions are significantly altered in 2D culture platforms compared to the in vivo conditions [64]. Commensurate with these descriptions, the development of novel angiogenesis protocols is highly recommended. To date, several 3D assays based on tumoroid/spheroid generation have been conducted to evaluate the angiogenesis in different tumor cells (Table 4) [67]. As mentioned above, it is thought that unicellular spheroids and multicellular tumoroids are valid avascular units and can mimic relatively in vivo cytoarchitectural features compared to the 2D culture systems.

Table 3 Advantages and disadvantages of different angiogenesis assays

Table 4 Some spheroid systems with various experimental protocols have been used for monitoring physiological and pathological angiogenesis

Impact of hypoxia on angiogenesis

Inside the body, solid tumor cells are exposed to hypoxia when O₂ levels drop below 21% which can worsen the prognosis of cancer individuals [68]. Due to micron-size dimensions, tumoroids/spheroids can provide diffusional limitations and radial gradients in terms of O₂, nutrients, micro- and macroelements, and waste byproducts [69]. Cells located at the deeper layers of organoid/tumoroid microstructures are more prone to hypoxic changes because of an imbalance between O₂ consumption and the limited distribution of nutrients [70]. It has been indicated that hypoxia is a potent angiogenesis stimulator via the regulation of several pro-angiogenic pathways. Besides the critical role of angiogenesis factors in different aspects of EC biology, hypoxic conditions can also influence vascular cell arrangement, and functions [68]. In response to hypoxic conditions, the activation of hypoxia-inducible factors (HIFs) can per se switch on the expression of multiple angiogenesis factors, leading to angiogenesis transition via direct interaction with cognate receptors on tumor cells, ECs, and other vascular cells [71]. HIFs consist of HIF-1α, -1β, -2α, and -3α with the potential (especially HIF-1α) to simultaneously alter the transcription of other genes such as vascular endothelial growth factor (VEGF), and erythropoietin following the attachment to hypoxia response elements (HREs) [72]. HIF-1α is inhibited via factor inhibiting HIF (FIH), and prolyl-hydroxylases (PHDs) when O₂ contents return to basal levels. In contrast, these factors (PHDs, and FIH) are inactive under hypoxic conditions which in turn promote the translocation of HIF-α into the nucleus and its interaction with HIF-β [73]. Hypoxic conditions result in excessive cytosolic hyperacidification due to the accumulation of waste byproducts, including lactate, pyruvate, and acetic acid in the central zone [74]. Of course, the intensity of the pH value is blunted from the central zone to the outer layers. The activation of HIF-1α triggers the enzymes of the anaerobic glycolysis pathway and heightens the intracellular levels of lactate (Fig. 2) [70, 75, 76]. In the presence of HIF-1α, the function of the Na⁺/H⁺ exchanger is altered to efflux accumulated proton ions and regulate intracellular pH homeostasis, leading to the reduction of ECM pH values [77]. Acidic conditions can increase the solubility of angiogenesis factors such as VEGF and activate relevant signaling pathway effectors such as MAPK/ERK in target cells. It should not be forgotten that excessive acidic conditions beyond the cell threshold can inhibit the angiogenic behaviors of ECs, leading to the promotion of necrotic cell death [78, 79]. In support of this statement, Mena et al. found that acid preconditioning (pH = 6.6) of endothelial colony-forming cells promotes vasculogenesis, and increases the adhesion, and cell resistance in response to hyperglycemic conditions and pro-inflammatory status [61]. Of course, the intensity of the pH value is blunted from the central zone to the outer layers.

Fig. 2

Copyright 2023. [79]. Cancer Cell International (Springer Nature Publishing Group). In the right panel, the schematic of tumor spheroid cell layers is indicated. Due to hyperacidification, lack of enough O₂, and other parameters, most of the cells in the central zone undergo apoptotic and necrotic changes. In response to these features, juxtaposed to the central zone can release HIF-1α along with several angiogenesis factors to stimulate the formation of blood vessels. These vascular units are indicated by typical capillary sprouts in the tumor mass periphery and anastomosis within the stroma. The existence of hypoxic conditions is an essential element for the promotion of angiogenesis in tumor spheroids/tumoroids. The right panel was designed by using BioRender's web-based software

Typical tumor spheroid structure. In the left panel, the multicellular tumor spheroid is composed of human adenocarcinoma colorectal HT-29 cells, HUVECs, and HFFF2 fibroblasts. Spheroids have an inner dark compact core area and are enclosed by several cells in the periphery (outer layers). The connection of cells is loose in the external layers, indicating higher proliferation capacity.

In an experiment conducted by Taghavi Narmi et al., they developed colon cancer tumoroids using human HT-29 adenocarcinoma cells, HFFF2 fibroblasts, and umbilical cord vein ECs (HUVECs) using hanging drop embedded in 2.5% methylcellulose solution [79]. Based on histological analysis, central cells exhibit typical features of necrotic changes with prominent pyknotic changes [79]. These conditions promoted the production of angiogenesis factors, especially endocan in the outer layers [79]. Schmitz et al. indicated a significant reduction of O₂ levels in mesenchymal stem cell (MSC) spheroids using CPOx-orange polystyrene microbeads, and OPAL Optical O₂ measurement system by monitoring UnaG hypoxia reporter protein [80]. Data indicated O₂ levels dropped below 1% (v/v) in spheroids containing about 3 × 10⁴ MSCs while these levels were near 2.5% (v/v) in a 2D culture system [80, 81]. Of course, it should be kept in mind that local O₂ levels are variable in cell microaggregates developed using different fabrication platforms. For instance, the O₂ tension is higher in the deep layer of MSC spheroids induced by hanging drop methods using Terasaki plates when compared to spheroids fabricated by direct culture on ultra-low attachment plates [80]. The activation of vascularization and accumulation of metabolic byproducts can lead to differences in temperature values compared to the surrounding tissues [82]. It seems that the active pro-angiogenesis properties increase the local temperature within the solid tumor masses while the progression of necrotic changes, accumulation of metabolic byproducts, and reduction of metabolic activity reduce the local cancer mass temperature compared to the healthy niches [82]. In an interesting experiment conducted by Kumar et al., they proved a temperature difference between the 3D tumoroid core and periphery composed of human HCT-8 colon cancer cells and NIH3T3 fibroblast cells using the fluorescent polymeric nano-thermometers. Data indicated fewer temperature values (~ 2.9 °C) in the core zone compared to the outer layers of the tumoroid system [83]. Therefore, one can hypothesize that the active metabolic state along with higher temperature values can help us in the evaluation of pro-angiogenesis status within the tumor parenchyma in in vitro conditions. Hypothermic conditions in the core of tumor mass are highly related to the lack of angiogenesis signaling and prominent necrotic changes as seen in real tumor masses. Besides, these features can stimulate specific signaling molecular pathways. For instance, several signaling pathways related to inflammation, angiogenesis, and epithelial-mesenchymal transition (EMT) were indicated in hepatocellular organoids [84]. Of note, prolonged hypoxic conditions can result in the expression of angiogenesis-related factors such as VEGF within the organoid systems [85]. Regarding the fact that most tumor cell types prefer glycolysis over oxidative phosphorylation, it seems that the lack of suitable oxygen levels can educate these cells to behave similarly to the in vivo-like conditions. In organoids exposed to hypoxic conditions, the proliferation of ECs and differentiation of stem cells and progenitors toward endothelial lineage is increased [86]. Each cell type can select specific spatial localization within the organoid/tumoroid structure. For example, ECs prefer the periphery of spheroids/organoids in the early days after development while the formation of vascular units and elongation of these cells help them to penetrate the deeper layers (Fig. 3) [87]. In line with this statement, in heterotypic spheroids consisting of ECs and MSCs, green fluorescent ECs can be detected in the periphery of these structures over time and promotion of angiogenesis response increases the EC migration into the central zone according to gradient density of angiogenesis factors [87]. These features highlight the importance of EC location within the tumoroid/spheroid system which can pre-determines the angiogenesis capacity. It is postulated that the poor access of innermost cells of tumoroids to O₂ can initiate the pro-angiogenesis signaling pathways while new vessel formation is promoted by the stimulation of outer layer ECs. It was suggested that ECs in the periphery of unicellular spheroids are more potent in generating capillary sprouts and outgrowth within the collagen gel [65]. Inside the multicellular spheroids composed of human endothelial and osteoblast lineages, ECs can generate the CD31⁺ microvessels in in vitro conditions and these vascular units can interconnect with surrounding capillaries after being transplanted into the target tissues [88]. Using appropriate ECM components and suitable cell types, the angiogenic potential of vascular cells can be stimulated [89]. In spheroids composed of ECs and smooth muscle cells (SMCs) within the methacrylated hyaluronic acid with fibrinogen, the expression of angiogenesis factors such as stromal-derived factor-1 alpha, HIF-1α, and angiopoietin 1 and migration capacity were in the maximum levels in EC-SMC spheroids compared to EC, and SMC spheroids [89]. These data indicate that heterotypic interaction can promote the function of ECs and thereby angiogenesis potential inside the tumoroids/spheroids. In breast cancer tumoroids consisting of MDA-MB-231 and/or MCF-7 cancer cell lines, lung ECs, and bone marrow MSCs, the localization of ECs is associated with breast cancer cell types and close interaction with MSCs in tumoroids. Cellular organization was more prominent in tumoroids containing MDA-MB-231 rather than MCF-7 cells. This effect would be related to the supportive role of MSCs in the stabilization of vascular units via direct juxtacrine interaction with ECs or pericytes [90, 91]. It is also mentioned that ECM-producing cells like fibroblasts can improve the angiogenic behavior of ECs within the tumoroid/spheroid structures [92]. Inside the body, fibroblasts, especially cancer-associated fibroblasts (CAFs), tend to localize in the core zone of tumors while proliferating cancer cells occupy the outer margins of solid tumors [93]. Of note, the exact location of fibroblasts within the tumoroid system determines morphological adaptation. For instance, CAFs and fibroblasts located near the core zone are round-shaped while these cells are elongated and flattened in the outer layer. This effect would be closely associated with topological net charge in which the deep layer exhibits positive values and these features are negative in the periphery of tumor masses [94]. It was shown that fibroblasts and especially CAFs can support tumor angiogenesis via the production of type I collagen, different pro-angiogenesis factors such as fibroblast growth factor (FGF), VEGF, etc., and stimulation of EMT phenomenon (Fig. 4) [95, 96]. In contrast to the cancer cells, E-cadherin and other adhesion molecules are normally distributed at the surface of normal cells, increasing the juxtacrine cell-to-cell interaction over time [97, 98]. Morphological changes and close interaction of cells within the spheroid/tumoroid system along with the hypoxic core are essential for angiogenesis potential [62, 99]. Emerging data have revealed that there is a close relationship between spheroid/tumoroid vascularization potential and activation of resistance mechanisms [100]. Ahn and co-workers developed unicellular HepG2 cells, and hybrid HepG2 plus HUVEC spheroids using fibrinogen matrix [100]. Compared to unicellular HepG2 spheroids, the expression of genes related to angiogenesis and vascular unit function (CD31, vWF, and FLT1), and metastasis (H19, VIM, LAMB3, ITGA5) were prominent in HepG2-HUVEC spheroids. These data confirmed that heterogeneous cell microstructures (such as tumoroids) can efficiently provide geometric clues for in vivo-like cell behavior and phenotype, especially cancer angiogenesis status [100]. Inside solid tumors, the existence of differentiation capacity from the epithelial-to-mesenchymal lineage, especially ECs, and other cell types can enhance the formation of intraparenchymal vessels, resulting in invasive tumor cell behavior and metastasis toward remote sites [101]. HepG2-HUVEC fibrin spheroids indicated eminent expression of EMT factors (LUG↑, MMP-9↑, and α-SMA↑), leading to the increase of intra-spheroid vascularization [100]. It has been indicated that ECs possess plasticity to acquire mesenchymal phenotype (EndMT) within the cancer parenchyma. Upon the activation of EndMT, ECs reduce protein levels of certain factors such as CD31, VE-cadherin, Tie-2, and vWF, and the expression of mesenchymal cell lineages such as α-SMA, type I/III collagen, and fibroblast-specific protein-1 is induced [102]. Inside the tumor niche, resistant cancer cells and CSCs prefer to locate at sites near the hypoxic zone to maintain their stemness features, angiogenesis potential (VEGF), and resistance mechanisms [103]. In contrast, the increase of O₂ levels inside TME leads to CSC-to-normal cancer cell maturation, and loss of stemness feature loss [104]. It should be noted that the development of vascular units within the tumoroid/spheroid system indicates activated endothelial differentiation of CSCs, and proliferation of ECs in response to hypoxic conditions. In the hypoxic conditions, glioma CSCs are prone to acquire EC phenotype by the activation of A3 adenosine receptor [105]. It was shown that the exposure of spheroids to specific culture conditions such as cyclic fluid shear stress can improve the angiogenesis potential and endothelial differentiation of adipose MSCs (vWF↑, and CD144↑) [106]. The application of specific ECM, and/or ECM-like substrates with different cell lineages (multicellular spheroids) can yield a suitable platform for the analysis of tumor angiogenesis. However, it should be kept in mind that providing a hypoxic niche inside spheroids/tumoroids using certain techniques is an essential factor in an efficient angiogenesis analysis. It is suggested that the mean diameter of avascular tumoroids/spheroids should exceed 400 µm for obtaining a hypoxic core [107].

Fig. 3

Copyright 2020 [228]. Journal of Molecular Medicine (Springer Nature Publishing Group)

The localization of human cord blood EC and bone marrow MSCs within the spheroids generated using agarose molds (Day 0 a–b). ECs and MSCs were stained with CellTrace™ Oregon Green® 488, and CellTrace™ Far Red Cell, respectively to be tracked within the spheroid structure. Immunofluorescence images indicate the localization of ECs in the periphery of spheroids (a, and b). Data showed that green CD31⁺ cells were located at the periphery of spheroids while red-colored α-SMA.⁺ MSCs distributed within the spheroid parenchyma. The nuclei were stained using DAPI. These data show that cell alignment and localization depend on types and functions within the spheroids in in vitro conditions.

Fig. 4

Copyright 2021. [236]. Frontiers in Bioengineering and Biotechnology (Frontiers Publishing Group)

Detection of ECM protein components [collagen IV (Col IV), collagen I (Col I), and fibronectin (FN)] in multicellular spheroids composed of breast HCC1954 cells (TC), PKH26-labeled dermal fibroblasts (hF), and Cell Tracker Deep Red-labeled HUVECs (ECs) with different ratios (TC 1: hF 1: EC 1, and TC 1: hF 3: EC 10) using immunofluorescence images. Spheroids were generated using ultra-low 96-well plates. Spheroids were incubated with VEGF [VEGF suppl. (0.5 ng/m)] or VEGF-deprived conditions (VEGF w/o) for 30 days, and exposed 2-day static culture system followed by agitation-based culture setting (rotation speed: 100 rpm). Data showed that fibronectin was produced in monotypic and heterotypic spheroid systems and is mainly at the center zone of spheroids, indicating the cancer cell origin. In contrast, the production of type I and IV collagen was promoted in the heterotypic spheroid system compared to the monotypic spheroids. The presence of VEGF can intensify the production of collagen by fibroblasts within the heterotypic spheroid system. These data highlight the role of cells in the production of certain components of ECM via the production of certain growth factors within the spheroid systems. The analyses were done in triplicate. Nuclei were stained with DAPI Scale bar, 100 μm.

During past decades, several techniques and assays have been used to assess the angiogenesis potential of cancer cell spheroids and tumoroids based on the EC function and activity. Among several techniques and approaches, spheroid-based sprouting angiogenesis is a simple, fast, and valid assay to measure the formation of new blood vessels and the activity of tip cells embedded in supporting dense matrices [67]. Sprouting parameters such as the number of sprouting and migrating ECs, mean envelope area, mean total outgrowth cell area, and the distance of ECs from the spheroid center, and border can be calculated in unicellular spheroids or multicellular spheroids composed of endothelial lineage and other cell types [108,109,110]. In an interesting study, Park and colleagues monitored the angiogenesis behavior of tumor spheroids composed of human fibroblasts with different cancer cell lines such as HepG2, U87MG, A549, and/or plasmacytoid dendritic cells in all-in-one-IMPACT system using the microfluidic platform and fibrin gel [111]. The formation of vascular sprouts within the different concentrations of fibrin hydrogel was assessed [111]. Several molecular analyses such as proteomic [i.e. immunofluorescence [112, 113], immunohistochemistry staining [114], western blotting [79], etc.], and genomic assays have been also to measure the angiogenesis status in several spheroid systems [62, 79, 115] following the exposure to different modalities [116,117,118].

Along with different in vitro spheroid-based angiogenesis assays, the transplantation of developed spheroids/tumoroids into animal models has been extensively used during the last decades [119]. Spheroid-plug model is one of the most applicable methods for the analysis of spheroid-derived angiogenesis in in vivo conditions. In this approach, unicellular and/or multicellular spheroids are embedded inside the supporting substrates, like Matrigel, etc., and directly injected into the subcutaneous area or transplanted into the target tissues [120, 121]. At distinct time points, the angiogenesis potential of transplanted spheroids/tumoroids was assessed using imaging techniques, i.e. ultrasonographic, proteomic, and genomic analyses [122]. Recently, Choi and co-workers investigated the formation of angiogenesis in a mouse xenograft model of oral mucosa after the injection of CAFs and head and neck squamous cell carcinoma (SCC) grown in a 2D monolayer and/or 3D spheroid culture systems [123]. Histological analyses revealed that the number of CD31⁺ was less in mice that received disassociated cells while the injection of spheroids resulted in the formation of a vascular bed with numerous CD31⁺ cells [123]. Interestingly, they found that the levels of exosomes (Exos) also increased in spheroids composed of CAFs, and SCC cells with the increase of angiogenesis potential (pdgf↑, vegf↑, vegfr-2↑, pdgfra↑). Data indicated that the presence of CAFs can increase the angiogenic potential of FaDu squamous cell carcinoma [123]. It has been shown that Exos are valid theranostics for monitoring molecular signatures in the parent cells and loading certain cargo for therapeutic purposes [124]. Exos are produced directly by the activity of the endosomal system inside the cytosol via the invagination of the endosome membrane. During this process, several signaling factors and pro-angiogenesis factors are sequestrated into the Exo lumen [125].

Due to their nano-sized scales, Exos can easily penetrate the spheroid structure for the analysis of angiogenesis potential. In most studies, supporting ECM is composed of collagen, gelatin, hyaluronic acid, polymeric carbohydrates such as alginate, and other substrates which can yield fibrous networks or hydrogel with nano- to micron-sized pores in the structure of spheroids/tumoroids [126,127,128]. To this end, Capik and co-workers incubated human EC spheroids with hypoxic oral SCC cell Exos for monitoring the angiogenesis potential [129]. Data indicated that exosomal miR-1825 led to the increase of sprouts in EC spheroids via the modulation of the TSC2/mTOR axis [129]. These data confirmed that Exos can efficiently harbor both genetics and proteomics in different cell layers within the spheroid structure. Whether the majority of Exos can be uptaken by cells located at outer or deep cell layers needs more elucidation. In an interesting study, paclitaxel/gemcitabine monophosphate-loaded Exos efficiently entered pancreatic ductal adenocarcinoma spheroids with about an average diameter of 300–350 µm. Immunofluorescence images revealed significant homing capability of fluorochrome-stained Exos in the deep layer of pancreatic ductal adenocarcinoma spheroids and orthotopic model in mice [130]. Hao and co-workers indicated the prominent penetrating properties of doxorubicin-loaded Exos in human adenocarcinoma A549 spheroids after 4 h in in vitro conditions [131]. These data show that Exos are valid diagnostics for the evaluation of pro-angiogenesis cargo. Thus, Exos can be used for the delivery of specific therapeutics into deep layers of tumoroids/spheroids using some sophisticated loading techniques.

Microfluidic devices and 3D bioprinting for fabrication of vascularized tumor spheroids

In recent years, 3D bioprinting technology along with microfluidic devices have been used for precise and spatial arrangement of cells and supporting materials to generate micro-sized aggregates and simulate in vivo tumor-like conditions [132]. Along with different bioprinting modalities, droplet-based bioprinting (such as inkjet, acoustic, and microvalve-based approaches) exhibits reproducibility, accuracy, adaptability to different substrates, etc. for the fabrication of tumor spheroids/organoids [133]. Using droplet-based bioprinting, both cell number and type can be controlled in the structure of final tumor spheroids [133]. Previously, Utama et al. used drop-on-demand bioprinter and alginate-based substrate for the fabrication of multicellular tumor spheroids (neuroblastoma, and lung cancer cell lines) with the potential to control parameters such as size, and dimensions of colonies [134]. Data indicated a rapid spheroid formation rate with high encapsulated cell numbers within certain dimensions. The current approach was eligible to preserve the stemness of neuroblastoma cells (CD133⁺ cells↑) within the tumor spheroids. Besides, the cell alignment and compactness were increased in 3D-bioprinted spheroids as compared with manually prepared spheroid counterparts. The presence of HIF-1α⁺ cells indicates typical hypoxic conditions in the inner layers of 3D-bioprinted spheroids which can be used for monitoring angiogenesis and drug screening [134]. In a similar work conducted by Hong and co-workers, they used a 3D bioprinting system for the evaluation of drug resistance in breast cancer spheroids containing MCF-7 CSCs and alginate-gelatin hydrogel [135]. The developed tumor spheroids preserve the stemness feature (CD44⁺/CD24⁻/ALDH⁺ cells↑) with simultaneous up-regulation of resistance markers such as GRP78 chaperon and ABCG2 [135].

In recent years microfluidic bioreactors have been increasingly used for the evaluation of angiogenesis response in tumor spheroids [100]. It has been shown that the integration of the tumor-on-a-chip technique with 3D bioprinting platforms can help us provide a heterogeneous TME and monitor angiogenesis as well [136]. Meng and co-workers fabricated 3D bioprinted modules consisting of photo-responsive microcapsules [GelMA core with EGF, and Au-functionalized PLGA film], A549 tumor cell droplets, endothelialized (HUVECs) microchannels, and fibroblast-loaded natural hydrogel. This platform can successfully mimic the TME and be eligible to monitor cancer cell migration in association with growth factor gradient and interaction with the stromal cells [137]. By combining 3D bioprinting technology and microfluidic devices, unicellular or multicellular tumor spheroids can be exposed directly to an EC-lined surface with predetermined flow rates and certain pro-, and anti-angiogenesis factors [138]. The angiogenesis rate is monitored in terms of vascularization area, and penetration of vascular cells to spheroid structure (Figs. 5, and 6) [100]. Han and co-workers studied the angiogenesis of U78 glioblastoma tumoroids plated on a bioprinted vascular niche composed of pulmonary fibroblasts and human ECs embedded in gelatin/alginate/fibrinogen composite [139]. Data confirmed the invagination of vascular ECs into tumoroid structure and migration of U78 cancer cells toward vessels and vice versa. On day 7, the expression of CD31 and α-actin is up-regulated coinciding with the formation of vascular network within the hydrogel. In the presence of anti-cancer compounds (temozolomide, and sunitinib), the intensity of vascular units was reduced in the tumoroid backbone compared to the cells treated with temozolomide alone. These features indicate the feasibility of the designed system for monitoring the efficiency of several anti-cancer drugs on certain tumor types in vitro [139].

Fig. 5

Copyright 2024. [138]. Biomaterials (Elsevier Publishing Group)

Application of microfluidic 3D culture system for monitoring the patient tumor (gastric adenocarcinoma)-derived spheroid angiogenesis response (A–E). The patient-derived tumor spheroids were generated using fibrin hydrogel. The microfluidic 3D culture system provided a valuable platform to measure the angiogenesis properties of spheroids after being exposed to HUVECs in the EC channel (A). The reciprocal interaction between the EC layer and hydrogel-embedded spheroids within the microfluidic 3D culture system (B). The existence of hydrostatic pressure stimulated tumor spheroids to release angiogenesis-related factors such as VEGF toward the EC channel (C). Tumor cell and EC growth were monitored using confocal microscopy for 6 days (D). After 14 days, the fluorescein-labeled Ulex Europaeus agglutinin I⁺ EC layer advanced toward Alexa Fluor 594-EpCAM.⁺ tumor spheroid to generate vascularized tumor mass. Scala bar: 10 µm.

Fig. 6

Copyright 2023. [100]. Acta Biomaterialia (Elsevier Publishing Group)

Comparison of lymphangiogenesis efficiency in tumor spheroids inside microfluidic chip device exposed to static and dynamic culture condition (a-e). Schematic illustration of interstitial flow effect on lymphangiogenesis and angiogenesis properties of tumor spheroids composed of fibrin-embedded HepG2 cells and HUVECs. Tumor spheroids (HepG2 cells + HUVECs) were injected and fixed in the central channel using fibrin clots containing vascular ECs and lymphatic ECs (a). Confocal images of angiogenesis (red-colored Alexa Fluor® 594 CD31⁺ cells) and lymphangiogenesis (green-colored Alexa Fluor® 488 podoplanin.⁺ cells) under static and dynamic culture conditions (b) Scale bars: 400 μm). Spheroid size (c), vascularization area (d), and lymphatic vessel area (e) were measured in conditions with static and dynamic culture systems (n = 4). Data indicated that both lymphangiogenesis and angiogenesis were stimulated in tumor spheroid systems after being exposed to a dynamic culture system. Non-paired student's t-test. ***p < 0.001. n.s: non-significant.

Under physiological conditions, the existence of shear stress with frictional forces is an essential element for the regulation of EC function and activity. Thus, the application of a perfusable culture system with simultaneous shear stress forces can yield reliable data compared to static culture platforms. In microfluidic systems, microfabrication approaches can be used for the fabrication of microchannels using suitable substrates for monitoring cell attachment, morphogenesis, and function in the dynamic aqueous phase [140]. In an interesting work, Miller and co-workers developed engineered vascular tissue consisting filament network composed of carbohydrate glass using 3D bioprinting [141]. The luminal surface was furnished with ECs and exposed to pulsative blood flow. Based on the complexity of TME, this approach can be applied to control several geometries such as vascular network dimension, EC function, impact of intervascular niche, and tumor cell behavior. The application of different cell lineages within certain substrates is also possible for achieving reliable in vivo-like data [141]. Using a tumor microfluidic model, immune cell function can be also monitored in response to tumoroids with different cell types [142]. In this regard, fibroblasts were co-incubated with different tumor cells (H69M lung cancer cells, OV90 ovarian cancer cells. SN12C kidney cancer cells) within the tumor-on-a-chips composed of PDMS for assessing angiogenesis potential [142]. The tumoroids were overlaid on HUVEC- and fibroblast-incorporated fibrin gel and vascularized tumoroids were evident after 7 days [142]. Application of continuous flow for 4 days showed that CAR T cells successfully penetrate the tumoroid microenvironment and interact with the apical surface vascular ECs. Along with the recruitment of CAR T cells into the tumor niche, the local IFN-γ levels were also increased, indicating the activation of CAR T cells after being exposed to tumor cells [142].

In most previously conducted works, ECs have been used as the main vascular cell component for monitoring angiogenesis in tumor model analyses. The inclusion of other vascular cells such as pericytes and perivascular niches can reflect more reliable in vitro data about the dynamic tumor cell growth comparably to in vivo conditions [143]. In an experiment conducted by Ngo et al., brain glioblastoma tumoroids were fabricated using brain microvascular ECs, pericytes, and astrocytes to monitor the possible role of perivascular cells in angiogenesis potential of tumoroids within the GelMA substrate [143]. Data indicated that mono, di, and triculture of ECs with pericytes, and astrocytes led to the formation of a primitive stable vascular network (CD31↑, ZO↑) within the tumor unicellular or multicellular aggregates. The presence of pericytes can increase the expression of tight junction molecules such as ZO, and CLDN5. Along with these changes, the expression of ECM components such as LAMA4 was also induced. The culture of GBM6 cell spheroids within the GelMA hydrogel containing ECs, pericytes, and astrocytes indicated numerous peripheral invading tumor cells after 7 days. On the other hand, ECs were also recruited to the proximity of tumor spheroids to generate vascular networks. Taken together, the existence of perivascular cells (pericytes) can stimulate the migration and metastasis of glioblastoma cells with enhanced vascular density [143].

Current bottlenecks and challenges

Despite the superiority of unicellular and multicellular spheroids over 2D culture systems in terms of cancer research, this platform faces some critical limitations that need further consideration. Compared to cultured cells in 2D systems, bright-field imaging and obtaining high-resolution scanning are usually difficult and laborious due to intricate geometries that affect light scattering, penetration, and absorption within the spheroid/tumoroid systems [144, 145]. These features make it difficult to make transparent images and study the central zone of multicellular complexes. Prolonged light exposure can also increase the possibly of phototoxicity and photobleaching effects that per se necessitate the application of more expensive techniques such as electron microscopy, and layer-by-layer fluorescence imaging [146, 147]. In most circumstances, the lack of an appropriate penetration rate or homogenous distribution of fluorochrome compounds reduces the possibility of certain biomarkers and positive cells within the deep layers of spheroid/tumoroid systems [7, 144, 148]. To fabricate interpretable 3D datasets, certain imaging software, and platforms with motorized and controllable microscope frames are mandatory [144]. It should not be forgotten that the mean diameter size of multicellular units is not completely similar which can affect the access of nutrients and other essential factors into central zones. In this regard, obtaining almost uniform data is problematic and makes the results difficult [149]. In contrast to in vivo conditions, the distribution of O₂ and various nutrients in the 3D culture system is restricted in the static culture systems. Of note, dynamic culture platforms can in part circumvent these pitfalls but it is not completely similar to biological systems [150]. In terms of anatomical microstructure, the tumor masses are enclosed by solid tissues while in in vitro spheroid/tumoroid cultures are surrounded by aqueous phases. These features allow the cells located at the external surface to proliferate more actively because of unlimited access to growth factors and cell culture elements [7].

Notwithstanding, each tumor has specific supporting ECM components and the development of spheroid/tumoroid systems with native ECM compositions needs standard protocols and sophisticated synthesis protocols. It is believed that ECM composition and variation in supporting substrates can affect the genetic traits, cellular behavior within the spheroid/tumoroid complex, and response to therapeutics and drug screening protocols [144, 151]. Compared to the real tumor mass, the in vitro multicellular systems possess a relatively simple microstructure with a limited number of ECM components. The entity of ECM can change during the culture periods and selection of cell ratio in tumoroid systems. Therefore, the selection of appropriate cells with relatively similar tumor mass ratios is mandatory to establish more realistic models and compare the in vitro and in vivo data [150]. In most spheroid/tumoroid models, the lack of microstructure interconnectivity, ECM alignment, and specific cell types such as cancer-associated fibroblasts (CAFs), tumor-associated macrophages (TAMs), and other vascular components such as pericytes can affect the dynamic growth of cancer cells and tumor mass behavior [144, 152]. Unlike in vivo conditions, spheroids/tumoroids are devoid of neuroimmunoendocrine interactions which allows cancer cells to proliferate more actively compared to other cell types [150]. It is believed that M2 TAMs can exert immunosuppressive properties with the potential to change tumor cell migration, drug sensitivity and ECM components [153]. Whether and how co-cultured fibroblasts can acquire in vivo-like stable phenotypes (CAFs) is associated with the production of several cytokines, and physical interaction with the other cells [150]. CAFs are actively present in the tumor matrix and likely produce a large fraction of ECM components (fibronectin, collagen, etc.) along with certain growth factors. It has been thought the number of CAFs and ECM production correlate with stable and continuous hypoxic conditions and low pH values [153]. The co-culture of ECs with other cells within the multicellular system cannot fully mimic tumor parenchyma vascular networks while constant shear stress and perfusion should be provided [154]. Direct evidence for low-content intercellular junction factors, i.e., E-cadherin, leads to formation of less compact spheroid/tumoroid system. In most circumstances, the up-regulation of N-cadherin instead of E-cadherin loosen the cell-to-cell interaction [146]. Of course, certain ECM components such as collagen can facilitate the compactness of spheroids/tumoroids. Unfortunately, creating a multicellular system with a dense collagen matrix is somehow impossible and needs intricate synthesis protocols that may damage the cells [145, 146]. These features closely affect the penetration and tumoricidal properties of immune cells [150, 155].

Conclusions

Tumoroids/spheroids provide a valid cost-effective, fast, precise, and reproducible in vitro platform to recapitulate in vivo-like conditions for the analysis of angiogenesis status in response to drugs and other factors [156]. Besides, both multicellular and unicellular tumor spheroids enable us to study the paracrine and juxtacrine interaction between the homotypic and heterotypic cells. In most previously conducted experiments, several parameters such as tumor cell dynamic, metastasis, drug screening, etc. have been analyzed more than the angiogenesis potential. Thus, the current review article aims to scrutinize the importance of angiogenesis/vascularization in the dynamic growth of the tumoroid/spheroid system. Based on several studies, endothelial lineage, and/or stem cell sources are used to mimic blood vessel structure within the multicellular and unicellular tumor spheroids, and thus type, intensity, and duration of angiogenesis responses can differ based on the cell components and supporting matrices. Like tumoroids composed of different cell lines, patient-derived tumoroids are also valid analytic tools to find appropriate medications and screen novel therapies targeting the angiogenesis potential. It should not be forgotten that tumoroids/spheroids have their limitations despite several advantages compared to conventional 2D culture systems. The entity, structure, and vascular cells involved in the development of vascular niches are not completely similar to in vivo conditions. Thus, additional efforts are needed to recapitulate different aspects of the tumor microenvironment, such as the inclusion of immune cells recapitulation of appropriate vessel morphologies, or appropriate basement membrane or ECM composition. Finding the exact in vivo-like cell-to-cell ratio is another challenge that restricts the applicability of 3D culture system-based assays for therapeutic purposes. Commensurate with these facts, future studies are suggested to address these issues for the development of powerful culture system tools comparable to in vivo tumor conditions.